# Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer

> **NCT00582634** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 4 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** docetaxel and cisplatin

## Key facts

- **NCT ID:** NCT00582634
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00582634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00582634, "Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00582634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*